Are you Dr. Koenig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
178 Oakland St
Wellesley, MA 02481Phone+1 301-356-4114Fax+1 617-726-5760
Summary
- Dr. Aaron Koenig, MD is a board certified psychiatrist in Wellesley, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania.
Education & Training
- University of Pennsylvania Health SystemFellowship, Geriatric Psychiatry, 2014 - 2015
- UPMC Medical EducationResidency, Psychiatry, 2010 - 2014
- Perelman School of Medicine at the University of PennsylvaniaClass of 2010
Certifications & Licensure
- MA State Medical License 2015 - 2026
- PA State Medical License 2013 - 2018
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
Publications & Presentations
PubMed
- 369 citationsEpidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi
Clinics in Liver Disease. 2016-05-01 - 836 citationsBrain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrumsSteven E. Arnold, Zoe Arvanitakis, Shannon L. Macauley-Rambach, Aaron M. Koenig, Hoau Yan Wang
Nature Reviews. Neurology. 2018-01-29 - 23 citationsThe technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s diseaseBianca A. Trombetta, Becky C. Carlyle, Aaron M. Koenig, Leslie M. Shaw, John Q. Trojanowski
Plos One. 2018-03-05
Press Mentions
- American Academy of Neurology, April 2-7April 20th, 2022
- Preliminary Study: Drug May Be Safe in Those with Mild Cognitive Impairment, Mild DementiaMarch 31st, 2022
- Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 in DepthMay 13th, 2021
- Join now to see all